Skip to content

Adding pegylated interferon to tenofovir improves odds of HBsAg loss in hepatitis B patients

Joerg Petersen, from the University of Hamburg, speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.

Gay men in UK recommended to receive HPV vaccination

Merck's grazoprevir/elbasvir combo shows high cure rates, including for people with cirrhosis and HIV/HCV co-infection

Mark Sulkowski, of Johns Hopkins University, speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.

Sofosbuvir/ledipasvir and AbbVie 2D regimen cure most people with HCV genotype 4

Anita Kohli, from the US National Institute of Allergy and Infectious Diseases (NIAID), speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.

Groundbreaking HIV vaccine's effects were real – and could be made to work better

Restoring and maintaining a high CD4 count possible for vast majority of people living with HIV in France

Dominique Costagliola, speaking at HIV Glasgow. Image courtesy of HIV Drug Therapy Glasgow 2014 (hivglasgow.org)

Sofosbuvir/ledipasvir with ribavirin is highly effective for people with decompensated cirrhosis

Steven Flamm, speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.

People living with HIV have high survival rates after liver transplants due to HCC

What are the barriers that could stop HIV treatment becoming HIV prevention?